找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Allergy and Asthma; The Basics to Best P Massoud Mahmoudi (Editor-in-Chief) Living reference work 20200th edition allergic diseases.allerg

[復(fù)制鏈接]
樓主: sesamoiditis
41#
發(fā)表于 2025-3-28 17:39:26 | 只看該作者
Anaphylaxis and Systemic Allergic Reactions,hylaxis is wheezing due to acute bronchospasm. Wheezing tends to occur particularly in patients with a history of asthma. Many of the symptoms of anaphylaxis are due to the effects of histamine, platelet-activating factor (PAF), and proteases on the cardiovascular, respiratory, and cutaneous systems
42#
發(fā)表于 2025-3-28 21:32:46 | 只看該作者
Aspirin or Nonsteroidal Drug-Exacerbated Respiratory Disease (AERD or NERD),gnosis of N-ERD is based on a medical history suggestive of the typical clinical manifestations, and in some patients, confirmation by an oral provocation test with aspirin can be performed when necessary. Treatment of N-ERD includes patient education for careful avoidance of COX-1 inhibitors, the u
43#
發(fā)表于 2025-3-29 00:19:46 | 只看該作者
Asthma in Athletes,of the presence or severity of EIB. It is important to treat EIB in a similar manner as treating asthma. Optimal treatment should not just decrease daily symptoms of asthma, but significantly attenuate or even abolish EIB. To achieve this, the health-care provider must understand the prevalence, pat
44#
發(fā)表于 2025-3-29 04:18:49 | 只看該作者
45#
發(fā)表于 2025-3-29 09:30:45 | 只看該作者
Bronchodilator Therapy for Asthma,ort-acting beta-agonists (SABAs) are the most effective medications available in relieving bronchospasm and preventing exercise-induced bronchospasm. LABAs, when used in fixed combination with inhaled GCs, are very effective in improving asthma control and are the preferred controller agents for ast
46#
發(fā)表于 2025-3-29 15:28:38 | 只看該作者
47#
發(fā)表于 2025-3-29 18:07:08 | 只看該作者
Childhood Asthma,the absence of respiratory tract infections. In all age groups, current asthma management guidelines focus on a stepwise approach to symptom and risk control while addressing comorbidities and other modifiable risk factors such as inhaler technique, treatment adherence, and environmental exposures.
48#
發(fā)表于 2025-3-29 22:29:13 | 只看該作者
49#
發(fā)表于 2025-3-30 02:26:13 | 只看該作者
50#
發(fā)表于 2025-3-30 07:26:57 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 22:50
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
成武县| 内丘县| 格尔木市| 鄂托克旗| 吉水县| 蒙阴县| 利津县| 神农架林区| 绍兴市| 南召县| 广州市| 宜良县| 龙口市| 历史| 隆昌县| 杭锦旗| 岳西县| 盱眙县| 会东县| 枣强县| 枣阳市| 三台县| 贵德县| 临泽县| 樟树市| 龙口市| 马龙县| 新田县| 淮北市| 苍南县| 武穴市| 余庆县| 亚东县| 宁远县| 江达县| 文山县| 余干县| 楚雄市| 来安县| 留坝县| 台前县|